Fig. 2From: Efficacy of the combination use of aprepitant and palonosetron for improving nausea in various moderately emetogenic chemotherapy regimensThe control rates for acute and delayed nausea and vomiting in the two-drug (palonosetron+DEX) and three-drug (NK1RA + palonosetron+DEX) groups after a propensity score matchingBack to article page